116 related articles for article (PubMed ID: 19041369)
1. Potential mechanisms of neuroprotection induced by low dose total-body gamma-irradiation in C57 mice administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Zhang Y; Li S; Liang Y; Wen C; Guo Q; Su B
Neurosci Lett; 2009 Jan; 450(2):106-10. PubMed ID: 19041369
[TBL] [Abstract][Full Text] [Related]
2. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
Liang Y; Li S; Zou Q; Su B
Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245
[TBL] [Abstract][Full Text] [Related]
3. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Sriram K; Miller DB; O'Callaghan JP
J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
[TBL] [Abstract][Full Text] [Related]
4. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H
Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
[TBL] [Abstract][Full Text] [Related]
7. Manganese does not alter the severe neurotoxicity of MPTP.
Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
[TBL] [Abstract][Full Text] [Related]
8. Defining "neuroinflammation".
O'Callaghan JP; Sriram K; Miller DB
Ann N Y Acad Sci; 2008 Oct; 1139():318-30. PubMed ID: 18991877
[TBL] [Abstract][Full Text] [Related]
9. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.
Rojo AI; Montero C; Salazar M; Close RM; Fernández-Ruiz J; Sánchez-González MA; de Sagarra MR; Jackson-Lewis V; Cavada C; Cuadrado A
Eur J Neurosci; 2006 Oct; 24(7):1874-84. PubMed ID: 17067291
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
11. Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo.
Kou J; Klorig DC; Bloomquist JR
Neurotoxicology; 2006 Sep; 27(5):826-34. PubMed ID: 16725203
[TBL] [Abstract][Full Text] [Related]
12. gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain.
Itoh N; Masuo Y; Yoshida Y; Cynshi O; Jishage K; Niki E
Neurosci Lett; 2006 Jul; 403(1-2):136-40. PubMed ID: 16716512
[TBL] [Abstract][Full Text] [Related]
13. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
[TBL] [Abstract][Full Text] [Related]
14. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
Kurkowska-Jastrzebska I; Bałkowiec-Iskra E; Ciesielska A; Joniec I; Cudna A; Zaremba MM; Członkowski A; Członkowska A
Int Immunopharmacol; 2009 Jun; 9(6):781-91. PubMed ID: 19286483
[TBL] [Abstract][Full Text] [Related]
15. Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity.
Liang Y; Li S; Guo Q; Zhang Y; Wen C; Zou Q; Su B
Brain Res; 2007 Oct; 1178():132-40. PubMed ID: 17900537
[TBL] [Abstract][Full Text] [Related]
16. Neuroanatomical mapping of DNA repair and antioxidative responses in mouse brain: Effects of a single dose of MPTP.
Sava V; Reunova O; Velasquez A; Song S; Sanchez-Ramos J
Neurotoxicology; 2006 Dec; 27(6):1080-93. PubMed ID: 16831462
[TBL] [Abstract][Full Text] [Related]
17. Does melatonin help save dopaminergic cells in MPTP-treated mice?
Ma J; Shaw VE; Mitrofanis J
Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
[TBL] [Abstract][Full Text] [Related]
18. A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in mice.
Knaryan VH; Samantaray S; Galoyan AA; Mohanakumar KP
Neurosci Lett; 2005 Mar; 375(3):187-91. PubMed ID: 15694258
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR
Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367
[TBL] [Abstract][Full Text] [Related]
20. Strain-specific sensitivity to MPTP of C57BL/6 and BALB/c mice is age dependent.
Filipov NM; Norwood AB; Sistrunk SC
Neuroreport; 2009 May; 20(7):713-7. PubMed ID: 19349914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]